Although direct evidence linking CD44 to TC remains limited, the protein’s well-established functions in other malignancies justify further exploration of its potential role in thyroid tumorigenesis, resistance to therapy, and clinical outcomes. This evidence concerns the gene CD44 and thyroiditis.